Table 3.
Comparison of inflammatory markers and biochemical parameters of PCOS between obese and non-obese patients with PCOS.
PCOS-BMI <25 | PCOS-BMI >25 | p | |
---|---|---|---|
Neopterin (nmol/L) | 15±10 | 11.2±11.5 | 0.372 |
IL-6 (ng/L) | 232±148.1 | 115±101 | 0.021 |
TNF-a (ng/L) | 313±248 | 212±242.1 | 0.290 |
CRP (mg/dl) | 0.5±0.5 | 1.5±1.3 | 0.018 |
N/L Ratio | 10.3±11 | 7.3±8 | 0.520 |
B12 (pg/ml) | 257±194.5 | 256±218.5 | 0.678 |
Total-C (mg/dl) | 196.5±54.3 | 187.1±49.1 | 0.709 |
TAG (mg/dl) | 116±41.3 | 156±59 | 0.029 |
Fasting B.G. (mg/dl) | 101±19.5 | 107.1±16 | 0.164 |
E2 (pg/ml) | 157.1±186 | 90±83.1 | 0.310 |
FG Score | 11.3±3.3 | 12±3.1 | 0.640 |
F.test. (uıU/ML) | 1.4±1 | 2±1.1 | 0.534 |
LH/FSH (muı/ml) | 2.3±1.2 | 2±1.4 | 0.309 |
WHR (cm) | 0.8±0.1 | 0.9±0.02 | 0.047 |
Data are presented as mean ± standard deviation. There are used t test and nonparametric Mann-Whitney U test. p values: p values denoting the outcomes of comparison of the parameters of biochemical obese patients with PCOS and non-obese patients with PCOS. p<0.05 was considered to be statistically significant. CRP – C-reactive protein; TNF-α – tumor necrosis factor-α; IL-1 – interleukin-1; IL-6 – interleukin-6; NLR – neutrophil to lymphocyte ratio; TAG – triglyceride; Total-C – total cholesterol; FSH – follicle-stimulating hormone; LH – luteinizing hormone; E2 – Estradiol2; F.test – free testosterone; BMI – Body Mass Index; WHG – waist-to-hip ratio; FG score – Ferriman-Gallowey score; Fasting B.G. – fasting blood glucose.